Pulmonary Sarcoidosis following Etanercept Treatment
Tumour necrosis factor (TNF) is an important cytokine involved in the pathology of a number of inflammatory conditions, and thus blockade with anti-TNF therapies is becoming the cornerstone in managing such diseases. With increasing use, evidence is collected for the association of sarcoid-like gran...
Main Authors: | Kuljeet Bhamra, Richard Stevens |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2012/724013 |
Similar Items
-
Pulmonary Sarcoidosis following Etanercept Treatment for Ankylosing Spondylitis: A Case Report and Review of the Literature
by: A. Majjad, et al.
Published: (2018-01-01) -
Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept
by: Marcella Amaral Horta Barbosa Vieira, et al. -
Lung Sarcoidosis in Etanercept Treated Rheumatoid Arthritis Patient: A Case Report and Review of the Literature
by: Supat Thongpooswan, et al.
Published: (2014-01-01) -
Pulmonary Sarcoidosis
by: S. E. Van Brummelen, et al.
Published: (2015-06-01) -
Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
by: Anna Felis-Giemza, et al.
Published: (2019-10-01)